Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, WC1E 6BT London, U.K.
Biochem Soc Trans. 2019 Jun 28;47(3):765-777. doi: 10.1042/BST20170564. Epub 2019 Jun 24.
Bacterial microcompartments (BMCs) are protein-bound prokaryotic organelles, discovered in cyanobacteria more than 60 years ago. Functionally similar to eukaryotic cellular organelles, BMCs compartment metabolic activities in the cytoplasm, foremost to increase local enzyme concentration and prevent toxic intermediates from damaging the cytosolic content. Advanced knowledge of the functional and structural properties of multiple types of BMCs, particularly over the last 10 years, have highlighted design principles of microcompartments. This has prompted new research into their potential to function as programmable synthetic nano-bioreactors and novel bio-materials with biotechnological and medical applications. Moreover, due to the involvement of microcompartments in bacterial pathogenesis and human health, BMCs have begun to gain attention as potential novel drug targets. This mini-review gives an overview of important synthetic biology developments in the bioengineering of BMCs and a perspective on future directions in the field.
细菌微隔间(BMCs)是一种与真核细胞细胞器具有相似功能的蛋白结合的原核细胞器,早在 60 多年前就在蓝细菌中被发现。BMC 将代谢活动局限在细胞质中,以增加局部酶浓度并防止有毒中间体对细胞质内容物造成损害。近年来,对多种类型 BMC 的功能和结构特性的深入了解,突出了微隔间的设计原则。这促使人们对其作为可编程合成纳米生物反应器和具有生物技术和医学应用的新型生物材料的潜力进行了新的研究。此外,由于微隔间参与了细菌发病机制和人类健康,BMC 开始作为潜在的新型药物靶点引起关注。这篇迷你综述概述了 BMC 的生物工程中重要的合成生物学进展,并对该领域的未来方向进行了展望。